Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Choksi Laboratories Ltd

NSE: CHOKSILA · BSE: 526546 · Healthcare · 26 announcements

Share price
₹192.00
Market cap
₹133.7 Cr
Revenue (annual)
₹46.01 Cr
Net profit (annual)
₹1.96 Cr
P/E (TTM)
61.9×Sector 53.1×
Promoter holding
31.48%+0.00% QoQ
FII holding
10.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:22 IST BSE
Management Change

Choksi Laboratories Management Change

Choksi Laboratories Ltd has re-appointed Ms. Himika Choksi as Whole Time Director for a five-year term effective from April 1, 2027, subject to shareholder approval.

17:53 IST BSE
Management Change

Choksi Laboratories Management Change

Choksi Laboratories appointed Mrs. Stela Choksi as CFO following Mr. Vyangesh Choksi's resignation. The transition occurred on May 18, 2026, ensuring leadership continuity.

17:34 IST BSE
Management Change

Choksi Laboratories Management Change

Choksi Laboratories appointed Mrs. Stela Choksi as Chief Financial Officer. This leadership change strengthens executive management and supports regulatory compliance for the listed entity.

16:50 IST BSE
Management Change

Choksi Laboratories Management Change

Mr. Vyangesh Choksi resigned as Chief Financial Officer of Choksi Laboratories, effective May 18, 2026. He remains the company's Whole Time Director.